Drug Profile
Levocabastine
Alternative Names: Histimet; Levophta; Levostab; Livistin; Livocab; Livostin; R 50547Latest Information Update: 16 Jul 2019
Price :
$50
*
At a glance
- Originator Janssen L.P.
- Developer Janssen; Janssen-Cilag; Kyowa Kirin; Nippon Shinyaku; Santen Pharmaceutical
- Class Antiallergics; Piperidines; Sedating antihistamines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Allergic conjunctivitis; Seasonal allergic rhinitis
Most Recent Events
- 01 Oct 2008 Kirin Pharma Company has merged with Kyowa Hakko to form Kyowa Hakko Kirin
- 06 May 2008 Launched for Allergic conjunctivitis in European Union (Intraocular)
- 06 May 2008 Launched for Allergic conjunctivitis in United Kingdom (Intraocular)